Study points to a new, effective treatment option for patients with mesothelioma
Combining the immunotherapy agent durvalumab with the chemotherapy agents pemetrexed and cisplatin or carboplatin may provide a new treatment option
Read moreCombining the immunotherapy agent durvalumab with the chemotherapy agents pemetrexed and cisplatin or carboplatin may provide a new treatment option
Read moreResearchers from the Centenary Institute have developed a new approach to fighting melanomas that fail to respond – or are
Read moreA number of late-phase studies in colorectal cancer have opened in recent months. Could one of your patients benefit from
Read moreResearchers at SMU have found a way to make chemotherapy drugs more lethal to HPV-infected cervical cancer cells without collateral
Read moreCancer cells sometimes develop resistance to the cytotoxic drugs used in chemotherapy. Figuring out why the treatment isn't working and
Read moreChemotherapy is widely used to treat cancer patients. During the treatment, chemotherapeutic agents affect various biochemical processes to kill or
Read moreDr. Leora Horwitz treats fewer and fewer Covid patients at NYU Langone Medical Center in New York City. Still, she
Read moreA micro-sized polymeric net wrapping around brain tumors, just like a fishing net around a shoal of fish: this is
Read moreFirst-line tebentafusp significantly improved overall survival (OS) when compared with immunotherapy or chemotherapy in patients with metastatic uveal melanoma in
Read moreDespite surgery and subsequent treatment with chemotherapy and radiation, the majority of patients experience recurrence of malignant brain tumors. Researchers
Read more